Laboratory studies (blood analysis, including tumor markers of free and total prostate specific antigen (PSA)), tumor markers (carcinoembryonic antigen (CEA) and cancer antigen (CA 19-9)) were unremarkable. Here, KLK3 is linked to neoplasm.